Literature DB >> 15896296

Ethanol alters cellular activation and CD14 partitioning in lipid rafts.

Qun Dai1, Jun Zhang, Stephen B Pruett.   

Abstract

Alcohol consumption interferes with innate immunity. In vivo EtOH administration suppresses cytokine responses induced through Toll-like receptor 4 (TLR4) and inhibits TLR4 signaling. Actually, EtOH exhibits a generalized suppressive effect on signaling and cytokine responses induced by through most TLRs. However, the underlying mechanism remains unknown. RAW264.7 cells were treated with LPS or co-treated with EtOH or with lipid raft-disrupting drugs. TNF-alpha production, IRAK-1 activation, and CD14 partition were evaluated. EtOH or nystatin, a lipid raft-disrupting drug, suppressed LPS-induced production of TNF-alpha. The suppressive effect of EtOH on LPS-induced TNF-alpha production was additive with that of methyl-beta-cyclodextrin (MCD), another lipid raft-disrupting drug. EtOH interfered with IRAK-1 activation, an early TLR4 intracellular signaling event. Cell fractionation analyses show that acute EtOH altered LPS-related partition of CD14, a critical component of the LPS receptor complex. These results suggest a novel mechanism of EtOH action that involves interference with lipid raft clustering induced by LPS. This membrane action of EtOH might be one of the mechanisms by which EtOH acts as a generalized suppressor for TLR signaling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15896296     DOI: 10.1016/j.bbrc.2005.04.088

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  28 in total

Review 1.  Role of lipid rafts in liver health and disease.

Authors:  Angela Dolganiuc
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

2.  Ethanol causes the redistribution of L1 cell adhesion molecule in lipid rafts.

Authors:  Ningfeng Tang; Benjamin Farah; Min He; Stephanie Fox; Alfred Malouf; Yoav Littner; Cynthia F Bearer
Journal:  J Neurochem       Date:  2011-10-11       Impact factor: 5.372

3.  Innate immunity and inflammation in sepsis: mechanisms of suppressed host resistance in mice treated with ethanol in a binge-drinking model.

Authors:  Stephen B Pruett; Ruping Fan; Bing Cheng; Mitzi Glover; Wei Tan; Xiaomin Deng
Journal:  Toxicol Sci       Date:  2010-07-12       Impact factor: 4.849

4.  Ethanol exposure suppresses bone marrow-derived dendritic cell inflammatory responses independent of TLR4 expression.

Authors:  Juan L Rendon; Brian A Janda; Monica E Bianco; Mashkoor A Choudhry
Journal:  J Interferon Cytokine Res       Date:  2012-07-19       Impact factor: 2.607

5.  Binge alcohol consumption 18 h after induction of sepsis in a mouse model causes rapid overgrowth of bacteria, a cytokine storm, and decreased survival.

Authors:  Minny Bhatty; Wei Tan; Maria Basco; Stephen Pruett; Bindu Nanduri
Journal:  Alcohol       Date:  2016-11-27       Impact factor: 2.405

6.  L1 cell adhesion molecule signaling is inhibited by ethanol in vivo.

Authors:  Yoav Littner; Ningfeng Tang; Min He; Cynthia F Bearer
Journal:  Alcohol Clin Exp Res       Date:  2012-10-10       Impact factor: 3.455

Review 7.  In vitro and in vivo models of acute alcohol exposure.

Authors:  Angela Dolganiuc; Gyongyi Szabo
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

8.  The anti-inflammatory effects of a methanolic extract from Radix Isatidis in murine macrophages and mice.

Authors:  Eun Kyung Shin; Dae Hwan Kim; Hwan Lim; Hyun-Kyung Shin; Jin-Kyung Kim
Journal:  Inflammation       Date:  2010-04       Impact factor: 4.092

9.  Ethanol/naltrexone interactions at the mu-opioid receptor. CLSM/FCS study in live cells.

Authors:  Vladana Vukojević; Yu Ming; Claudio D'Addario; Rudolf Rigler; Björn Johansson; Lars Terenius
Journal:  PLoS One       Date:  2008-12-23       Impact factor: 3.240

10.  Ethanol inhibits LPS-induced signaling and modulates cytokine production in peritoneal macrophages in vivo in a model for binge drinking.

Authors:  Stephen B Pruett; Ruping Fan
Journal:  BMC Immunol       Date:  2009-09-18       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.